Drug pricing watchdogs worry that President Donald Trump’s plan to assess 100% tariffs on some imported brand-name drugs could leave patients out of pocket. But that fate is far from certain, as the Trump administration announced as part of a broader April 2 order on tariffs for imported brand name pharmaceuticals. Drug manufacturers who agree to move production to the United States will face…